Vivo Capital

United States
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
Founded:1996
Firm Location:United States • Massachusetts • New York, New York • San Francisco, California • Irvine, California • Palo Alto, California • Menlo Park, California • Beijing • Los Altos, California • Hong Kong • Taiwan • Shanghai • San Francisco Bay Area
Vivo Capital Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Gaurav Aggarwal, Managing Director at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
Photo of Chen Bian, Associate at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA), Investors in Shanghai
+17
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
Photo of Kevin dai, Managing Director at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA)
+21
Photo of Nathan Dau, Managing Director at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Photo of DanDan Dong, Managing Director at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Shanghai, Investors in Palo Alto (CA)
Photo of Edgar Engleman, Managing Partner at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
Photo of Frank Kung, Managing Partner at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
Photo of Xiaoyang li, Associate at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A)
+5
Photo of Yixuan Li, Senior Associate at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Photo of David Liu, Managing Director at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Taiwan, Investors in Shanghai, Investors in Beijing, Investors in Palo Alto (CA)
Photo of Zhongyi Lu, Principal at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Photo of Hongbo Lu, Partner at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA)
+17
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA)
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Photo of Daniel Qin, Associate at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Investors in Security (Seed), Investors in Security (Series A), Investors in Marketplaces (Series A), Investors in Marketplaces (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Security (Seed), Investors in Marketplaces (Series A), Investors in Security (Series A), Investors in Marketplaces (Seed)
+5
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA)
Photo of Jo Shen, Venture Partner at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in San Francisco (CA)
Photo of Joseph Siletto, Managing Director at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Massachusetts, Investors in San Francisco (CA)
+21
Photo of Priscilla Sugianto, Senior Associate at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Santa Monica (CA), Investors in United States
+21
Photo of Yuh-geng Tsay, Venture Partner at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
+17
Photo of Jason Wang, Senior Associate at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Menlo Park (CA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Enterprise (Seed), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Seed)
+9
Photo of Scott Whitcup, Venture Partner at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)
Photo of Daisy Xu, Managing Director at Vivo Capital
Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Taiwan, Investors in Palo Alto (CA), Investors in Shanghai
Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A)
+5
Photo of Chloe Zhang, Principal at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Beijing, Investors in Shanghai, Investors in Hong Kong, Investors in Taiwan, Investors in Palo Alto (CA)
+9
Photo of Lingfei Zhao, Associate at Vivo Capital
n/a
$25.0M
($10.0M - $50.0M)
Investors in Palo Alto (CA)